Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Awadhesh Kumar

Showing results (21-30 of 427) with videos related to

Pageof 43
Sort By:
Diabetes Research and Clinical Practice|June 14, 2020
Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative reviewAwadhesh Kumar Singh, Kamlesh Khunti
Indian Journal of Endocrinology and Metabolism|February 21, 2017
Recent cardiovascular outcome trials of antidiabetic drugs: A comparative analysisAwadhesh Kumar Singh, Ritu Singh
Diabetes & Metabolic Syndrome|May 30, 2020
Cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in Asians with type 2 diabetes: A systematic review and meta-analysis of cardiovascular outcome trialsAwadhesh Kumar Singh, Ritu Singh
Diabetes & Metabolic Syndrome|June 1, 2020
Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?Awadhesh Kumar Singh, Ritu Singh
World Journal of Cardiology|August 18, 2022
Metabolic and cardiovascular benefits with combination therapy of SGLT-2 inhibitors and GLP-1 receptor agonists in type 2 diabetesAwadhesh Kumar Singh, Ritu Singh
World Journal of Diabetes|September 2, 2022
Renin-angiotensin system blockers-SGLT2 inhibitors-mineralocorticoid receptor antagonists in diabetic kidney disease: A tale of the past two decades!Awadhesh Kumar Singh, Ritu Singh
Journal of Indian Society of Periodontology|September 23, 2015
The periosteum eversion technique for coverage of denuded root surfaceAwadhesh Kumar Singh, Preeti Kiran
Expert Review of Clinical Pharmacology|January 7, 2016
Sodium-glucose co-transporter-2 inhibitors as add-on therapy to insulin: rationale and evidencesAwadhesh Kumar Singh, Ritu Singh
Indian Journal of Endocrinology and Metabolism|December 23, 2015
Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progressAwadhesh Kumar Singh, Ritu Singh
Expert Review of Clinical Pharmacology|March 1, 2016
Is gliclazide a sulfonylurea with difference? A review in 2016Awadhesh Kumar Singh, Ritu Singh
Pageof 43

Showing results (21-30 of 427) with videos related to

Sort By:
Pageof 43
Diabetes Research and Clinical Practice|June 14, 2020
Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative reviewAwadhesh Kumar Singh, Kamlesh Khunti
Indian Journal of Endocrinology and Metabolism|February 21, 2017
Recent cardiovascular outcome trials of antidiabetic drugs: A comparative analysisAwadhesh Kumar Singh, Ritu Singh
Diabetes & Metabolic Syndrome|May 30, 2020
Cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in Asians with type 2 diabetes: A systematic review and meta-analysis of cardiovascular outcome trialsAwadhesh Kumar Singh, Ritu Singh
Diabetes & Metabolic Syndrome|June 1, 2020
Does poor glucose control increase the severity and mortality in patients with diabetes and COVID-19?Awadhesh Kumar Singh, Ritu Singh
World Journal of Cardiology|August 18, 2022
Metabolic and cardiovascular benefits with combination therapy of SGLT-2 inhibitors and GLP-1 receptor agonists in type 2 diabetesAwadhesh Kumar Singh, Ritu Singh
World Journal of Diabetes|September 2, 2022
Renin-angiotensin system blockers-SGLT2 inhibitors-mineralocorticoid receptor antagonists in diabetic kidney disease: A tale of the past two decades!Awadhesh Kumar Singh, Ritu Singh
Journal of Indian Society of Periodontology|September 23, 2015
The periosteum eversion technique for coverage of denuded root surfaceAwadhesh Kumar Singh, Preeti Kiran
Expert Review of Clinical Pharmacology|January 7, 2016
Sodium-glucose co-transporter-2 inhibitors as add-on therapy to insulin: rationale and evidencesAwadhesh Kumar Singh, Ritu Singh
Indian Journal of Endocrinology and Metabolism|December 23, 2015
Can anti-Mullerian hormone replace ultrasonographic evaluation in polycystic ovary syndrome? A review of current progressAwadhesh Kumar Singh, Ritu Singh
Expert Review of Clinical Pharmacology|March 1, 2016
Is gliclazide a sulfonylurea with difference? A review in 2016Awadhesh Kumar Singh, Ritu Singh
Pageof 43